Royalty Pharma
RPRX
$34.56
Share price
-1.54%
Change (1 day)
29.88%
Change (1 year)
Categories
Market capitalization of Royalty Pharma (RPRX)
Market cap: $19.43 Billion USD
As of June 2025 Royalty Pharma has a market cap of $19.43 Billion USD. This makes Royalty Pharma the world's 1053th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Royalty Pharma from 2020 to 2025
End of year Market Cap
| Year | Marketcap | Change |
|---|---|---|
| 2025 | $19.43 B | 29.13% |
| 2024 | $15.04 B | -10.66% |
| 2023 | $16.84 B | -3.38% |
| 2022 | $17.43 B | 1.85% |
| 2021 | $17.11 B | -11.89% |
| 2020 | $19.42 B |
End of Day market cap according to different sources
On Jun 17th, 2025 the market cap of Royalty Pharma was reported to be:
$19.42 Billion USD
$19.43 Billion USD
Market capitalization for similar companies or competitors
| Name | Marketcap | Market cap differencediff. | Country |
|---|---|---|---|
 ANI Pharmaceuticals ANIP | $1.37 B | -92.94% | 🇺🇸 USA |
 Abbott Laboratories ABT | $230.14 B | 1,084.43% | 🇺🇸 USA |
 Eli Lilly LLY | $710.32 B | 3,555.62% | 🇺🇸 USA |